Valora Therapeutics

Valora Therapeutics is a biotechnology company developing novel immunotherapies using its proprietary AbLec (Antibody-Lectin chimera) platform. This platform targets specific sugar molecules on cells to modulate glyco-immune checkpoints, offering a new approach to restoring proper immunological competency. The technology, licensed from Stanford University, has potential applications in oncology, autoimmune diseases, and other therapeutic areas.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $30M

Date: 20-Nov-2024

Investors: Avalon BioVentures, Bregua Corporation, TigerGene, Alexandria Venture Investments, Correlation Ventures

Markets: Biotechnology, Immunotherapy, Oncology, Autoimmune Diseases, Biopharma, Clinical Trials

HQ: San Diego, California, United States

Founded: 2023

Website: https://valoratherapeutics.com/

LinkedIn: https://www.linkedin.com/company/valora-therapeutics-inc

Twitter:

Instagram: